Participants A total of 500 371 subjects aged 40–69 years were eligible for the analysis, after excluding those with prevalent HPV-associated diseases at baseline and those who had withdrawn their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback